ADMA Biologics 관리
관리 기준 확인 3/4
ADMA Biologics CEO는 Adam Grossman, Jan2007 에 임명되었습니다 의 임기는 17.83 년입니다. 총 연간 보상은 $ 6.04M, 12.4% 로 구성됩니다. 12.4% 급여 및 87.6% 보너스(회사 주식 및 옵션 포함). 는 $ 48.02M 가치에 해당하는 회사 주식의 1.07% 직접 소유합니다. 48.02M. 경영진과 이사회의 평균 재임 기간은 각각 0.8 년과 12.3 년입니다.
주요 정보
Adam Grossman
최고 경영자
US$6.0m
총 보상
| CEO 급여 비율 | 12.4% |
| CEO 임기 | 17.8yrs |
| CEO 소유권 | 1.1% |
| 경영진 평균 재임 기간 | less than a year |
| 이사회 평균 재임 기간 | 12.3yrs |
최근 관리 업데이트
Recent updates
ADMA Biologics, Inc.'s (NASDAQ:ADMA) 27% Price Boost Is Out Of Tune With Revenues
Oct 09
ADMA Biologics: Riding High On ASCENIV's Success
Oct 02ADMA Biologics, Inc.'s (NASDAQ:ADMA) Intrinsic Value Is Potentially 57% Above Its Share Price
Sep 06ADMA Biologics' (NASDAQ:ADMA) Strong Earnings Are Of Good Quality
Aug 16ADMA Biologics: A Compelling GARP Stock For Biotech Investors
Jul 27ADMA Biologics, Inc. (NASDAQ:ADMA) Stock Rockets 25% As Investors Are Less Pessimistic Than Expected
Jul 24Is ADMA Biologics (NASDAQ:ADMA) Using Too Much Debt?
Jul 17Is ADMA Biologics, Inc. (NASDAQ:ADMA) Trading At A 43% Discount?
May 30ADMA Biologics, Inc. Just Beat EPS By 45%: Here's What Analysts Think Will Happen Next
May 13Giving ADMA Biologics A Well-Deserved 'Booyah'
May 12ADMA Biologics, Inc.'s (NASDAQ:ADMA) Prospects Need A Boost To Lift Shares
May 08Is ADMA Biologics (NASDAQ:ADMA) A Risky Investment?
Apr 04Rising Margins And Product Promise Drive ADMA Biologics Forward (Rating Upgrade)
Apr 03ADMA Biologics: On A Roll Entering 2024
Jan 19Is There An Opportunity With ADMA Biologics, Inc.'s (NASDAQ:ADMA) 50% Undervaluation?
Jan 09ADMA Biologics, Inc. (NASDAQ:ADMA) Surges 30% Yet Its Low P/S Is No Reason For Excitement
Jan 09We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt
Oct 25We Think ADMA Biologics (NASDAQ:ADMA) Has A Fair Chunk Of Debt
Jun 10The Market Doesn't Like What It Sees From ADMA Biologics, Inc.'s (NASDAQ:ADMA) Revenues Yet
May 12ADMA Biologics: Strong Growth Is Clearing The Path To Profitability
Aug 21ADMA Biologics GAAP EPS of -$0.07, revenue of $33.9M
Aug 10ADMA Biologics (NASDAQ:ADMA) Is Carrying A Fair Bit Of Debt
Jun 01ADMA Biologics: A Path To Profits Looks Clear
May 12ADMA: Pertinent Updates
Apr 18ADMA Biologics' 2021 Numbers Showed Continued Strong Execution
Mar 29ADMA Biologics: 2021 Was Tough
Jan 18CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$68m |
| Jun 30 2024 | n/a | n/a | US$35m |
| Mar 31 2024 | n/a | n/a | -US$4m |
| Dec 31 2023 | US$6m | US$750k | -US$28m |
| Sep 30 2023 | n/a | n/a | -US$23m |
| Jun 30 2023 | n/a | n/a | -US$40m |
| Mar 31 2023 | n/a | n/a | -US$48m |
| Dec 31 2022 | US$3m | US$637k | -US$66m |
| Sep 30 2022 | n/a | n/a | -US$70m |
| Jun 30 2022 | n/a | n/a | -US$73m |
| Mar 31 2022 | n/a | n/a | -US$78m |
| Dec 31 2021 | US$4m | US$618k | -US$72m |
| Sep 30 2021 | n/a | n/a | -US$74m |
| Jun 30 2021 | n/a | n/a | -US$74m |
| Mar 31 2021 | n/a | n/a | -US$75m |
| Dec 31 2020 | US$2m | US$600k | -US$76m |
| Sep 30 2020 | n/a | n/a | -US$67m |
| Jun 30 2020 | n/a | n/a | -US$61m |
| Mar 31 2020 | n/a | n/a | -US$54m |
| Dec 31 2019 | US$2m | US$536k | -US$48m |
| Sep 30 2019 | n/a | n/a | -US$56m |
| Jun 30 2019 | n/a | n/a | -US$59m |
| Mar 31 2019 | n/a | n/a | -US$61m |
| Dec 31 2018 | US$2m | US$536k | -US$66m |
| Sep 30 2018 | n/a | n/a | -US$61m |
| Jun 30 2018 | n/a | n/a | -US$61m |
| Mar 31 2018 | n/a | n/a | -US$55m |
| Dec 31 2017 | US$3m | US$494k | -US$44m |
보상 대 시장: Adam 의 총 보상 ($USD 6.04M )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 6.60M ).
보상과 수익: Adam 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Adam Grossman (47 yo)
17.8yrs
테뉴어
US$6,039,649
보상
Mr. Adam S. Grossman serves as Director at BioFlorida Inc since August 2021. He is the Co-Founder of ADMA Biologics, Inc. and has been its Chief Executive Officer and President since October 2011 and 2007...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder | 17.8yrs | US$6.04m | 1.07% $ 48.0m | |
| Co-Founder & Vice Chairman of the Board | 17.8yrs | US$284.72k | 0.22% $ 9.7m | |
| CFO & Treasurer | less than a year | 데이터 없음 | 0.091% $ 4.1m | |
| COO & Senior VP of Compliance | less than a year | 데이터 없음 | 0.055% $ 2.5m | |
| Vice President of Marketing & Corporate Development | no data | 데이터 없음 | 데이터 없음 | |
| Executive Director of Sales | less than a year | 데이터 없음 | 데이터 없음 | |
| Vice President of Human Resources | 2.8yrs | 데이터 없음 | 데이터 없음 | |
| Senior Director of Business Development & Corporate Strategy | no data | 데이터 없음 | 데이터 없음 |
0.8yrs
평균 재임 기간
49yo
평균 연령
경험이 풍부한 관리: ADMA 의 관리팀은 경험 (평균 재직 기간 0.8 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder | 17.8yrs | US$6.04m | 1.07% $ 48.0m | |
| Co-Founder & Vice Chairman of the Board | 17.8yrs | US$284.72k | 0.22% $ 9.7m | |
| Independent Director | 12.5yrs | US$280.72k | 0.025% $ 1.1m | |
| Independent Chairman | 17.8yrs | US$290.22k | 0.022% $ 997.8k | |
| Independent Director | 3.1yrs | US$272.34k | 0.097% $ 4.4m | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Independent Director | 12.3yrs | US$275.09k | 0.060% $ 2.7m | |
| Member of Scientific Advisory Board | 10.4yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 10.4yrs | 데이터 없음 | 데이터 없음 | |
| Independent Director | 1.1yrs | US$231.12k | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | no data | 데이터 없음 | 데이터 없음 |
12.3yrs
평균 재임 기간
60yo
평균 연령
경험이 풍부한 이사회: ADMA 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 12.3 년).